Shanshan Hong

Costunolide covalently targets NACHT domain of NLRP3 to inhibit inflammasome activation and alleviate NLRP3-driven inflammatory diseases

Haowen Xu, Jiahao Chen, Pan Chen et al. · Acta Pharmaceutica Sinica B · 2022 · 75 citations · Full text

Targeted paclitaxel nanoparticles modified with follicle-stimulating hormone β 81–95 peptide show effective antitumor activity against ovarian carcinoma

Xiaoyan Zhang, Jun Chen, Yu Kang et al. · International Journal of Pharmaceutics · 2013 · 38 citations

Nanomedicine, Paclitaxel Nanoparticles, Drug Targeting +10

Follicle-stimulating hormone peptide-conjugated nanoparticles for targeted shRNA delivery lead to effective gro-α silencing and antitumor activity against ovarian cancer

Shanshan Hong, Mingxing Zhang, Meng Zhang et al. · Drug Delivery · 2018 · 30 citations · Full text

Nanoparticles, Nanotherapeutics, Engineering +23

Cardamonin inhibits LPS-induced inflammatory responses and prevents acute lung injury by targeting myeloid differentiation factor 2

Libin Yang, Wu Luo, Qiuyan Zhang et al. · Phytomedicine · 2021 · 29 citations

Acute Lung Injury, Inflammation, Anti-inflammatory +11

Tabersonine, a natural NLRP3 inhibitor, suppresses inflammasome activation in macrophages and attenuate NLRP3-driven diseases in mice

Haowen Xu, Weifeng Li, Shanshan Hong et al. · Acta Pharmacologica Sinica · 2023 · 28 citations · Full text

Inflammation, Natural Nlrp3 Inhibitor, Anti-inflammatory +12